Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease (original) (raw)

Treatment of arrhythmias in patients with congestive heart failure

Daniel Lustgarten

Current Treatment Options in Cardiovascular Medicine

View PDFchevron_right

Sixty-six episodes of ventricular fibrillation within four hours: electrical stability restored by propafenone

Pietro Bellone

International Journal of Cardiology, 1994

View PDFchevron_right

Pharmacotherapy of Cardiac Arrhythmias-Basic Science for Clinicians

Chinmay Patel

Pacing and Clinical Electrophysiology, 2009

View PDFchevron_right

Prognosis of patients with ventricular tachycardia or fibrillation and a normal electrophysiologic study

Román Lezáun

American Heart Journal, 1991

View PDFchevron_right

Presence of Pathological Arrhythmia in Patients Admitted to the Emergency Room for Cardiac Arrhythmia

Ahtisham Hassan

Pakistan Journal of Medical and Health Sciences, 2023

View PDFchevron_right

Effects of propafenone on ventricular arrhythmias: Double-blind, parallel, randomized, placebo-controlled dose-ranging study

Juan Guerrero

American Heart Journal, 1988

View PDFchevron_right

The Electrocardiogram and Drug-Induced Arrhythmias

Bassem Chehab

Kansas Journal of Medicine, 2011

View PDFchevron_right

ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary

Jaap Deckers

Circulation, 2003

View PDFchevron_right

The Use of Ivabradine in a Patient with Idiopathic Ventricular Arrhythmia Originating from the Left Ventricular Summit

Ro Lu

2020

View PDFchevron_right

Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: Results of a mmulticenter trial

Koonlawee Nademanee

The American Journal of Cardiology, 1996

View PDFchevron_right

Prevention and treatment of ventricular dysrhythmias

Jitu Vohra

Heart, 1971

View PDFchevron_right

Medida do átrio esquerdo em pacientes com suspeita de insuficiência cardíaca com fração de ejeção normal

Mario Luiz Ribeiro

Arquivos Brasileiros de Cardiologia, 2012

View PDFchevron_right

Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives

Massimo Grimaldi

Journal of Clinical Medicine

View PDFchevron_right

Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care setting

Urs Eriksson

Cardiology Journal

View PDFchevron_right

Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation

Augusto Cobo

International Journal of Cardiology, 2013

View PDFchevron_right

Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias

Massimo Grimaldi

Journal of Clinical Medicine

View PDFchevron_right

Pronóstico de una población inicialmente candidata a trasplante cardíaco controlada con tratamiento médico

José Juan Gómez Diego

Revista Española de Cardiología, 2005

View PDFchevron_right

Influence of left ventricular dysfunction on flecainide therapy

Allan Greenspan

Journal of the American College of Cardiology, 1987

View PDFchevron_right

Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide

Raphael Smith

The American Journal of Cardiology, 1981

View PDFchevron_right

Drug treatment in heart failure

Eva Lonn

BMJ, 1998

View PDFchevron_right

Short- and long-term experience with flecainide acetate in the management of refractory life-threatening ventricular arrhythmias

Roop Lal

Journal of the American College of Cardiology, 1985

View PDFchevron_right

Chapter 63: Ventricular tachycardia and ventricular fibrillation

Indrajit Choudhuri

2015

View PDFchevron_right

Flecainide: Current status and perspectives in arrhythmia management

Sokratis Pastromas

World Journal of Cardiology, 2015

View PDFchevron_right

Multicentre, Cross-Sectional Study of Ventricular Arrhythmias in Chronically Haemodialysed Patients

Luca Gondoni

The Lancet, 1988

View PDFchevron_right

Management of Patients with Atrial Fibrillation: Focus on Treatment Options

Paweł Matusik

Journal of Atrial Fibrillation, 2016

View PDFchevron_right

Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment

giovanni russo

Heart, 2010

View PDFchevron_right

Atrial Fibrillation: Pharmacological Therapy

Chinmay Patel

Current Problems in Cardiology, 2011

View PDFchevron_right

The search for novel antiarrhythmic strategies

Antonio Zaza

European Heart Journal, 1998

View PDFchevron_right

CORRIGENDUM: JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias

Naokata Sumitomo

Circulation journal, 2021

View PDFchevron_right

Preservation of ventricular function by treatment of ventricular fibrillation with phenylephrine

Mark Midei

Journal of the American College of Cardiology, 1990

View PDFchevron_right

Flecainide: Steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia

Allan Greenspan

Journal of the American College of Cardiology, 1986

View PDFchevron_right

High-dose flecainide with low-dose β-blocker therapy in catecholaminergic polymorphic ventricular tachycardia: A case report and review of the literature

Doris Boeckelmann

Journal of Cardiology Cases, 2015

View PDFchevron_right

Práticas Não Farmacológicas No Manejo Da Insuficiência Cardíaca

Suellen Maier

Revista da Sociedade de Cardiologia do Estado de São Paulo, 2020

View PDFchevron_right

Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate

Roop Lal

The American Journal of Cardiology, 1986

View PDFchevron_right

Ventricular Arrhythmia and Adrenal Insufficiency After Fluorouracil: New Side Effects of an Old Drug

joseph ragaz

JNCI Journal of the National Cancer Institute, 1993

View PDFchevron_right